{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-264838","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2022-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.754224+00:00","generated_at":"2026-06-23T02:34:43.545557+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Elevance Health Q3 GAAP EPS $6.68, adj. $7.53; revenue up 11.5%; raises FY2022 outlook","bullets":["GAAP net income $6.68/share vs $6.79 adjusted; adjusted EPS $7.53, up 10.9% YoY.","Operating revenue $39.6B (+11.5% YoY), driven by membership growth and premium rate increases.","Medical membership 47.3M, up 2.2M YoY (+4.9%), with growth in Medicaid, commercial fee-based, and Medicare Advantage.","FY2022 GAAP net income guidance raised to >$25.33/share; adjusted net income >$28.95/share.","Q4 dividend declared $1.28/share, payable Dec 21, 2022 to holders of record Dec 5."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-264838","json":"https://secwatch.observer/filing/0001193125-22-264838.json","markdown":"https://secwatch.observer/filing/0001193125-22-264838.md","text":"https://secwatch.observer/filing/0001193125-22-264838.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312522264838/0001193125-22-264838-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312522264838/d401070d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:34:43.545557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}